Skip to content

Study of Shayyamutra (Enuresis) in children by using Aamravatadi granules

Evaluation of the Efficacy of Aamravatadi Granules in Shayyamutra (Enuresis) in children - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085738
Enrollment
30
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

None listed

Sponsors

Dr Snehal Suresh Nigade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with age group of 05 to 12 years of either sex will be selected. History of bed-wetting at least twice in a week The patient whose parents are ready to participate in clinical trial by giving informed written assent.

Exclusion criteria

Exclusion criteria: Patients other than 05 to 12 year age group. Patients with any known case of - CNS disordersEpilepsy Spina Bifida Diabetes Mellitus Diabetes Insipidus Urinary Tract Infections Any Obstruction in Lower Urinary Tract Like Posterior urethral valve stenosis, distal urethral stenosis.

Design outcomes

Primary

MeasureTime frame
The symptoms of Shayyamutra are expected to be reduced after the use of Ayurvedic formulation in children.Timepoint: 15 days study with follow up on 7th and 15th day (0,07,15)

Secondary

MeasureTime frame
To study the adverse effect of Aamravatadi Granules in Shayyamutra if anyTimepoint: 15 day study with follow up on 7th day and 15th day (0,07,15)

Countries

India

Contacts

Public ContactDr.Snehal Suresh Nigade
drdeepak77@rediffmail.com9923220055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026